BioNTech gets $145m funding boost for African vaccine plants

Coalition for Epidemic Preparedness Innovations and vaccine maker expand partnership

WATCH: Growth in Southern Africa lifts Life Healthcare

Business Day TV spoke to Life Healthcare's CEO Peter Wharton-Hood

Litigating against NHI is a last resort, says Life Healthcare CEO

Peter Wharton-Hood advocates for ‘constructive engagement’ and closer collaboration

China approves Eli Lilly diabetes drug

Tirzepatide cleared for use, intensifying competition with Novo Nordisk in the biggest  Asian market

WATCH: Netcare weathers tough economic conditions

Business Day TV speaks to Richard Friedland, CEO of Netcare

AstraZeneca to build facility in Singapore for cancer drugs

CEO Pascal Soriot laudes Singapore as a top global venue for investment

Netcare laments ‘lost chance’ to listen to private sector on NHI

Total paid patient days for the first half decreased by 0.8% compared with a year ago due to sector seasonability

Switzerland’s Sanova bets on product launches in second half

The world’s largest maker of hearing aids expects its sales to grow by 6%-9%

Poor performance in China hurts Siemens Healthineers

The company has been grappling with an anticorruption campaign targeting the bribing of doctors

Netcare expects strong performance by occupational health business

Private hospital operator predicts growth in  revenue of up to 4.4% at the halfway stage

Runaway obesity drug demand drives Novo Nordisk profit boost

Danish drugmaker’s shares rise 260% since Wegovy’s US launch

Life Healthcare flags first-half earnings leap

Several items affected the results including the completion of the sale of AMG

Philips shares jump on $1.1bn US settlement

The medical devices maker agrees to settle all personal injury claims in the country, ending uncertainty that had slashed its market value

UnitedHealth says hack will cost it $1.6bn in 2024

The conglomerate has nevertheless maintained its earnings forecast